Spruce Biosciences, Inc. (SPRB) stock
SPRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$43.31+0.42 (+0.98%)
Close on Nov 13, 2026Market cap $124.47MP/E –Yield –
Spruce Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Spruce Biosciences's enterprise value was $37.97M on Nov 11, 2026, against $46.19M a year earlier. Over the last 5 years it ranged from -$69.95M to $1.64B, with a median of -$15.98M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $37.97M | -2.5% |
| 2025 | Dec 31, 2025 | $38.92M | – |
| 2024 | Dec 31, 2024 | -$40.60M | -369.8% |
| 2023 | Dec 29, 2023 | $15.05M | – |
| 2022 | Dec 30, 2022 | -$59.64M | -454.0% |
| 2021 | Dec 31, 2021 | $16.85M | – |
| 2020 | Dec 31, 2020 | -$47.70M | – |
See a number that looks wrong?